CDTX
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. (CDTX) has 3 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jan 7, 2026.
The most active filer is President & CEO Stein Jeffrey with 4 filings. Insiders have net bought $339K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jeffrey L. Stein
- Employees:38
- HQ:San Diego, CA, US
- IPO:2015-04-15
Insider Buying
$339K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Stein JeffreyFirst filing | President & CEO | Purchase | 645 | $100K | Jan 7 | SEC ↗ |
Stein JeffreyFirst filing | President & CEO | Purchase | 750 | $89K | Jan 7 | SEC ↗ |
Stein JeffreyFirst filing | President & CEO | Purchase | 367 | $50K | Jan 7 | SEC ↗ |
Stein JeffreyFirst filing | President & CEO | Purchase | 2,500 | $100K | Jan 7 | SEC ↗ |